Atkinson Edward Morrow III sold VRTX
February 25, 2026 · Form 4 insider transaction
Atkinson Edward Morrow III sold 668 shares of Vertex Pharmaceuticals Incorporated at $486.35 per share, a transaction worth $324.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
668
Price
$486.35
Total value
$324.9K
InsiderAtkinson Edward Morrow III
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 25, 2026
Filing dateFebruary 26, 2026
Shares owned after18,432
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 08/11/2025.